Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
November 22, 2024
Alcohol use was the most common predictor of escalating cannabis vaping among youth and young adults, independent of demographic factors, according to research by UTHealth Houston published this month in the journal Social Science & Medicine.
November 11, 2024
Adolescents who meet the recommended guidelines of nine to 11 hours of sleep per day were shown to have a significantly lower risk of hypertension, according to a new study from UTHealth Houston.
November 1, 2024
Medicare-certified home health agencies, which are key to allowing older adults to age in place, are increasingly going through ownership changes, raising concerns about health care spending, workforce, and quality of care, according to a study by UTHealth Houston.
October 21, 2024
A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the Institute of Psychiatry, Psychology & Neuroscience at King’s College London; and the University of East London.
October 10, 2024
Researchers at UTHealth Houston have been awarded an $8.1 million grant by the National Institutes of Health (NIH) to examine skeletal stem cells as potential drivers of craniofacial bone diseases and deformities. The study is led by Noriaki Ono, DDS, PhD, associate professor of orthodontics, and diagnostic and biomedical sciences at UTHealth Houston School of Dentistry.
October 10, 2024
Ashley Hallock, 35, describes the day she joined a clinical trial studying stem cells for bipolar disorder as the most important day of her life.
“For me, it was a godsend,” she said.
October 9, 2024
Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.
October 8, 2024
An intervention study to improve outcomes for cancer survivors and enhance primary care capacity, funded with a $4.8 million grant from the National Cancer Institute, will be implemented by UTHealth Houston researchers in partnership with eight Texas primary care community health centers that treat under- and uninsured patients.
October 7, 2024
UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease.
The recipient, 79-year-old Terrie Frankel, received the infusion last week.
October 1, 2024
UTHealth Houston School of Public Health will partner with the U.S. Department of Health and Human Services Office of the National Coordinator (ONC) to equip students with the knowledge and skills needed to pursue successful careers in public service, particularly in health and human services.
Use the form below to perform a new search.